A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors 
NHS Industries Postpones Filing of Annual Financial Statements and MD&A Due to COVID-19 Related Delays
VANCOUVER, BC / ACCESSWIRE / April 16, 2020 / NHS Industries Ltd. (CSE:NHS) (the "Company" or "NHS") has postponed filing...
Retrotope Initiates Project to Test RT001 in an Animal Model of Lung Damage to Protect Against COVID-19 Impact
LOS ALTOS, CA / ACCESSWIRE / April 16, 2020 / Retrotope announced today that it has initiated experiments to determine...
American Kidney Fund Coronavirus Emergency Fund Nears 7,000 Applications from Low-Income Kidney Patients; Recognizes Generous Corporate Donors Helping to Meet Unprecedented Need for Assistance
Alnylam Pharmaceuticals, Mallinckrodt Pharmaceuticals and Spherix Global Insights join list of corporations, foundations and associations stepping up to help reduce...
Plus Therapeutics to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020
AUSTIN, TX / ACCESSWIRE / April 16, 2020 / Plus Therapeutics, Inc. (NASDAQ:PSTV) (the "Company"), today announced that it will...
National Health Investors to Hold Virtual Shareholder Meeting
MURFREESBORO, TN / ACCESSWIRE / April 16, 2020 / National Health Investors, Inc. (NYSE:NHI) announced today that due to public...
Legacy ER & Urgent Care Adds Telehealth and Nurse Hotline in Response to COVID-19
Patients are delaying medical care as household accidents increase FRISCO, TX / ACCESSWIRE / April 16, 2020 / To provide...
DeMelle OncoPharma to Present at the April 2020 Virtual Investor Summit
Presentation with live audio webcast on Thursday, April 23 at 2:00 PM ET, immediately followed by an interactive Q&A session...
Rising Biosciences, Inc. Launches Production of Oxithymol(TM) Disinfectant in Response to Ohio Governor’s Appeal for Help Battling the COVID-19 Pandemic
Rising Biosciences, Inc. Launches Production of Oxithymol™ Disinfectant in Response to Ohio Governor's Appeal for Help Battling the COVID-19 Pandemic...
Immune Therapeutics Inc and Forte Biotechnology Intl Corp Sign Sub-Licensing Agreement for Animal Health Applications
Immune Therapeutics Announces Settlement with Major Creditors as part of licensing agreementImmune Therapeutics Announces Filing of 10K Extension Under SEC...
Sanvello Offers Free Clinician Dashboard to Mental Health Professionals to Support COVID-19 Response
Sanvello for Clinicians empowers mental health professionals to deliver telehealth services on a HIPAA-compliant platform with an extensive library of...
Netsmart Launches Telehealth App to Help Providers Deliver Virtual Care
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Netsmart has announced the successful launch of the Netsmart Telehealth Mobile App to implement a consumer telehealth...
Dosimetry Market Buoyant by Increasing Emphasis on Medical Staff Health Check-up; Coronavirus Outbreak Turns out to be a Damper: FMI Study
Surge in the number of cancer patients and the subsequent demand for internal radiotherapy devices will continue to drive the...
Adial Pharmaceuticals Verifies Proprietary Genetic Test in Landmark ONWARD(TM) Pivotal Phase 3 Clinical Trial
Adial Expects to Expand Use of Test to Planned Opioid Use Disorder Clinical Trials CHARLOTTESVILLE, VA / ACCESSWIRE / April...
Hemp Naturals Premium CBD Gummies are now available at Sunny Isles Citgo
MIAMI, FL / ACCESSWIRE / April 16, 2020 / Hemp Naturals Inc. (OTC PINK:HPMM) has proudly announced that it has...
CordovaCann Appoints Star Buds CEO Brian Ruden as Special Advisor
TORONTO, ON / ACCESSWIRE / April 16, 2020 / CordovaCann Corp. (CSE:CDVA) (OTCQB:LVRLF) ("Cordova" or the "Company"), a cannabis-focused consumer...
Patients Choice Laboratories and Indiana Health Care Association Partner to Bring COVID-19 Testing to Long Term Care Facilities
INDIANAPOLIS, IN / ACCESSWIRE / April 16, 2020 / Patients Choice Laboratories (PCL), a leading life sciences company, has partnered...
Enzolytics Update
PLANO, TX / ACCESSWIRE / April 16, 2020 / Enzolytics- (OTC PINK:ENZC) is pleased to update shareholders on the current corporate...
Jaguar Health Enters Deal with Atlas Sciences to Develop NP-500, a Jaguar Non-Core Plant-based Type II Diabetes Drug Candidate
Jaguar concurrently receives $1.5 million and exclusive 10-year license from purchaser to develop and commercialize NP-500 through sale of NP-500...
Viveve Announces Approval of Viveve 2.0 System in Canada
Viveve 2.0 System now available throughout North America, Asia, and over 30 European countries ENGLEWOOD, CO / ACCESSWIRE / April...
Aytu BioScience Announces Positive Results from an Independently Conducted Clinical Study of the Company’s Licensed COVID-19 IgG/IgM Point-of-Care Rapid Test
Independent clinical study demonstrates test accuracy of 98.0% and 94.1% for IgG and IgM, respectively, when using PCR-positive cases as...